Phesgo
Active substance: pertuzumab, trastuzumab
pertuzumab, trastuzumab
Centralised EU authorisationActive
Marketing holder: Roche Registration GmbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Products containing pertuzumab in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 7 |
|
| US 3 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-4abb-7595-aa15-2e6c2d9d03be,01a120c3-b042-7150-940d-05bc1c510f6f,01a120c3-d38a-7ce7-95ba-6cdbfa2316bb,01a120c5-0ba3-7060-88df-afd647364da8;count=4 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-306b-773e-b8cf-599d494647eb;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/005386
- Registration status
- Active
- ATC code
- L01XY
Sources
- product · EMA · EMEA/H/C/005386 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005386 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005386 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/005386 · Verified 2026-10-09